Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

823 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Androgen receptor serine 81 mediates Pin1 interaction and activity.
La Montagna R, Caligiuri I, Maranta P, Lucchetti C, Esposito L, Paggi MG, Toffoli G, Rizzolio F, Giordano A. La Montagna R, et al. Among authors: esposito l. Cell Cycle. 2012 Sep 15;11(18):3415-20. doi: 10.4161/cc.21730. Epub 2012 Aug 16. Cell Cycle. 2012. PMID: 22894932 Free PMC article.
ATP-noncompetitive CDK inhibitors for cancer therapy: an overview.
Abate AA, Pentimalli F, Esposito L, Giordano A. Abate AA, et al. Among authors: esposito l. Expert Opin Investig Drugs. 2013 Jul;22(7):895-906. doi: 10.1517/13543784.2013.798641. Epub 2013 Jun 4. Expert Opin Investig Drugs. 2013. PMID: 23735075 Review.
Treatment for glioma recurrence: new hope?
Esposito L, Caligiuri I, Giordano A. Esposito L, et al. Cancer Biol Ther. 2010 Jan;9(1):40-1. doi: 10.4161/cbt.9.1.10806. Epub 2010 Jan 1. Cancer Biol Ther. 2010. PMID: 20023371 Free article. No abstract available.
Could Puralpha be a cancer target?
Esposito L, Giordano A. Esposito L, et al. Cancer Biol Ther. 2008 Dec;7(12):1936-7. doi: 10.4161/cbt.7.12.7167. Epub 2008 Dec 9. Cancer Biol Ther. 2008. PMID: 18981716 Free article. No abstract available.
p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab.
Vici P, Sperati F, Maugeri-Saccà M, Melucci E, Di Benedetto A, Di Lauro L, Pizzuti L, Sergi D, Terrenato I, Esposito L, Iannuzzi CA, Pasquale R, Botti C, Fuhrman B, Giordano A, Mottolese M, Barba M. Vici P, et al. Among authors: esposito l. Oncotarget. 2014 Nov 15;5(21):10382-92. doi: 10.18632/oncotarget.2060. Oncotarget. 2014. PMID: 25071015 Free PMC article.
Lung Cancer: Are we up to the Challenge?
Esposito L, Conti D, Ailavajhala R, Khalil N, Giordano A. Esposito L, et al. Curr Genomics. 2010 Nov;11(7):513-8. doi: 10.2174/138920210793175903. Curr Genomics. 2010. PMID: 21532835 Free PMC article.
823 results